These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 19650159

  • 1. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.
    Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, Endo H, Takahashi H, Inamori M, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A.
    Hepatology; 2009 Sep; 50(3):772-80. PubMed ID: 19650159
    [Abstract] [Full Text] [Related]

  • 2. Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis.
    Fujita K, Imajo K, Shinohara Y, Nozaki Y, Wada K, Yoneda M, Endo H, Takahashi H, Abe Y, Inamori M, Shimamura T, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A.
    J Pharmacol Sci; 2011 Sep; 115(3):270-3. PubMed ID: 21350309
    [Abstract] [Full Text] [Related]

  • 3. A lipidomic analysis of nonalcoholic fatty liver disease.
    Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ.
    Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
    [Abstract] [Full Text] [Related]

  • 4. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    Shindo N, Fujisawa T, Sugimoto K, Nojima K, Oze-Fukai A, Yoshikawa Y, Wang X, Yasuda O, Ikegami H, Rakugi H.
    J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
    [Abstract] [Full Text] [Related]

  • 5. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
    Jiang ZG, Tapper EB, Connelly MA, Pimentel CF, Feldbrügge L, Kim M, Krawczyk S, Afdhal N, Robson SC, Herman MA, Otvos JD, Mukamal KJ, Lai M.
    Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
    [Abstract] [Full Text] [Related]

  • 6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?
    Gambino R, Cassader M, Pagano G, Durazzo M, Musso G.
    Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986
    [Abstract] [Full Text] [Related]

  • 8. Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis.
    Risikesan J, Heebøll S, Kumarathas I, Søndergaard E, Johansen RF, Ringgaard S, Aagaard NK, Sandahl TD, Villadsen GE, Gormsen LC, Frystyk J, Jensen MD, Grønbæk H, Nielsen S.
    J Lipid Res; 2024 Jul; 65(7):100580. PubMed ID: 38901559
    [Abstract] [Full Text] [Related]

  • 9. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis.
    Zhu L, Baker SS, Liu W, Tao MH, Patel R, Nowak NJ, Baker RD.
    Metabolism; 2011 Jul; 60(7):1001-11. PubMed ID: 21075404
    [Abstract] [Full Text] [Related]

  • 10. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
    Nomura K, Yamanouchi T.
    J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
    [Abstract] [Full Text] [Related]

  • 11. Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.
    Fujii Y, Nouso K, Matsushita H, Kariyama K, Sakurai T, Takahashi Y, Chiba H, Hui SP, Ito Y, Ohta M, Okada H.
    J Appl Lab Med; 2020 Nov 01; 5(6):1206-1215. PubMed ID: 32674154
    [Abstract] [Full Text] [Related]

  • 12. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M, Cansby E, Nuñez-Durán E, Pirazzi C, Ståhlman M, Stenfeldt E, Smith U, Borén J, Mahlapuu M.
    FASEB J; 2015 Apr 01; 29(4):1564-76. PubMed ID: 25609431
    [Abstract] [Full Text] [Related]

  • 13. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
    Rau M, Schilling AK, Meertens J, Hering I, Weiss J, Jurowich C, Kudlich T, Hermanns HM, Bantel H, Beyersdorf N, Geier A.
    J Immunol; 2016 Jan 01; 196(1):97-105. PubMed ID: 26621860
    [Abstract] [Full Text] [Related]

  • 14. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.
    Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY.
    Dig Dis Sci; 2005 Dec 01; 50(12):2338-43. PubMed ID: 16416185
    [Abstract] [Full Text] [Related]

  • 15. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.
    Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, Sanyal AJ.
    Gastroenterology; 2008 Feb 01; 134(2):568-76. PubMed ID: 18082745
    [Abstract] [Full Text] [Related]

  • 16. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
    Cano A, Buqué X, Martínez-Uña M, Aurrekoetxea I, Menor A, García-Rodríguez JL, Lu SC, Martínez-Chantar ML, Mato JM, Ochoa B, Aspichueta P.
    Hepatology; 2011 Dec 01; 54(6):1975-86. PubMed ID: 21837751
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
    Musso G, Gambino R, Cassader M.
    J Nutr Biochem; 2010 Sep 01; 21(9):834-40. PubMed ID: 19733470
    [Abstract] [Full Text] [Related]

  • 18. The plasma lipidomic signature of nonalcoholic steatohepatitis.
    Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ.
    Hepatology; 2009 Dec 01; 50(6):1827-38. PubMed ID: 19937697
    [Abstract] [Full Text] [Related]

  • 19. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis.
    Musso G, Gambino R, De Michieli F, Biroli G, Fagà E, Pagano G, Cassader M.
    Ann Med; 2008 Dec 01; 40(5):383-94. PubMed ID: 18484349
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein synthesis in nonalcoholic steatohepatitis.
    Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS.
    Hepatology; 2002 Apr 01; 35(4):898-904. PubMed ID: 11915037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.